Association between use of HMG CoA reductase inhibitors and mortality in HIV-infected patients.

by Richard D Moore, John G Bartlett, Joel E Gallant
Published 2011-01-01

28 Optimised ART and alloBMT to reduce HIV reservoirs

by Christine M. Durand, Adam Capoferri, Andrew D. Redd, Daniel S. Rosenbloom, Joel E. Gallant, Ayla E. Cash, Daniel Xu, Roberto Ramirez, Robert F. Siliciano, Richard F. Ambinder
Published 2017-07-01

A Randomized Trial of Time-Limited Antiretroviral Therapy in Acute/Early HIV Infection.

by Joseph B Margolick, Linda Apuzzo, Joel Singer, Hubert Wong, Terry Lee, Joel E Gallant, Phillippe El-Helou, Mona R Loutfy, Anita Rachlis, Christopher Fraser, Kenneth Kasper, Cécile Tremblay, Harout Tossonian, Brian Conway
Published 2015-01-01

Hepatitis C virus testing in adults living with HIV: a need for improved screening efforts.

by Baligh R Yehia, Ramin S Herati, John A Fleishman, Joel E Gallant, Allison L Agwu, Stephen A Berry, P Todd Korthuis, Richard D Moore, Joshua P Metlay, Kelly A Gebo, HIV Research Network
Published 2014-01-01

HIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance Testing.

by Soo-Yon Rhee, Michael R Jordan, Elliot Raizes, Arlene Chua, Neil Parkin, Rami Kantor, Gert U Van Zyl, Irene Mukui, Mina C Hosseinipour, Lisa M Frenkel, Nicaise Ndembi, Raph L Hamers, Tobias F Rinke de Wit, Carole L Wallis, Ravindra K Gupta, Joseph Fokam, Clement Zeh, Jonathan M Schapiro, Sergio Carmona, David Katzenstein, Michele Tang, Avelin F Aghokeng, Tulio De Oliveira, Annemarie M J Wensing, Joel E Gallant, Mark A Wainberg, Douglas D Richman, Joseph E Fitzgibbon, Marco Schito, Silvia Bertagnolio, Chunfu Yang, Robert W Shafer
Published 2015-01-01